News

Researchers are tackling a major challenge in food safety—drug-resistant "superbugs"—using a protective culture called Hafnia alvei B16.

If used around the world, mitigation methods could reduce the carbon dioxide emissions produced by gas-fired power by as much as 71%.

The use of new imaging methods has enabled the identification of novel structures on the surface of B cells, which affect the distribution and potentially the function of their antigen receptors.

A research team has discovered a method for modifying the function of an enzyme crucial to fat production, which could lead to more effective treatments for childhood obesity and cancer.

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness.

The US Food and Drug Administration has given a new Alzheimer’s drug the green light. The compound, lecanemab (Leqembi) is a monoclonal antibody (mAb), part of a new class of treatments that target the underlying mechanism of disease. It was approved using the FDA’s accelerated approval pathway.

Glial cells are known for guaranteeing optimal working conditions for nerve cells, but a study has discovered that, in rodents, a certain type of glial cell also plays an important role in spatial learning.

One of the first studies using machine learning techniques to design drug formulations has shown promise for reducing the time and cost associated with drug development.

Researchers have developed a nanotechnology-driven solution to locally enhance T-cell functions without producing unwanted systemic side effects.

A new study evaluating the effectiveness of therapeutic techniques used to treat depression has shown that performing acts of kindness can also alleviate depression symptoms.